ITEMS IN AFP WITH KEYWORD:
Peripheral Vascular Disease
Feb 1, 2017 Issue
Peripheral Vascular Disease: Treatment in Older Adults [FPIN's Help Desk Answers]
PVD can be effectively treated with supervised exercise therapy, cilostazol, lipid-lowering therapy, and antiplatelet therapy. All of these treatments increase pain-free walking distance. Antiplatelet therapy also decreases the need for surgical revascularization. The best treatment is supervised ex...
Dec 15, 2014 Issue
Peripheral Artery Disease Screening and Cardiovascular Disease Risk Assessment With the Ankle–Brachial Index in Adults: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk assessment with the ankle-brachial index (ABI) in adults.
Dec 15, 2014 Issue
Peripheral Artery Disease Screening and Cardiovascular Disease Risk Assessment with the Ankle-Brachial Index in Adults [Putting Prevention into Practice]
J.P. is a 40-year-old man with a 15 pack-year smoking history. His father has type 2 diabetes mellitus. J.P.'s vital signs, weight, and lipid levels are within normal limits. At his office visit, he brings an advertisement for a health fair with information on screening for peripheral artery disease...
Peripheral arterial disease (PAD) is atherosclerosis leading to narrowing of the major arteries distal to the aortic arch. The most common presenting symptom is claudication; however, only 10% of patients have classic claudication. Approximately 8 to 12 million Americans have PAD, including 15% to 2...
May 15, 2012 Issue
ACCF/AHA Update Peripheral Artery Disease Management Guideline [Practice Guidelines]
The American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) have updated their 2005 guideline on the management of peripheral artery disease (PAD) based on new data, with particular focus on lower extremity and abdominal aortic disease. Recommendations for renal and mesenteric disease remain the same.
Supervised exercise programs are recommended to produce clinically significant improvements in walking distance in patients with stable intermittent claudication.
Case study: A 57-year-old man visits your office for refills of simvastatin (Zocor) and paroxetine (Paxil). He says his friend had “a bypass operation on the arteries in his legs,” and asks if you think he should be “checked for that disease.” He has never had symptoms of claudication.
What are the effects of treatments for persons with chronic peripheral arterial disease?
Peripheral vascular disease is a manifestation of systemic atherosclerosis that leads to significant narrowing of arteries distal to the arch of the aorta. The most common symptom of peripheral vascular disease is intermittent claudication. At other times, peripheral vascular disease leads to acute ...
Feb 1, 2006 Issue
Screening for Peripheral Arterial Disease: Recommendation Statement [U.S. Preventive Services Task Force]
This statement summarizes the USPSTF recommendations on screening for peripheral arterial disease and the supporting scientific evidence and updates the 1996 recommendations contained in theGuide to Clinical Preventive Services, 2nd ed.